274610 CDC progress on male reproductive health and men's health

Tuesday, October 30, 2012 : 10:50 AM - 11:10 AM

Lee Warner, PhD , Division of Reproductive Health, Center for Disease Control and Prevention, Atlanta, GA
     
The Centers for Disease Control and Prevention (CDC) has a longstanding history of conducting scientific and programmatic activities with direct relevance to male reproductive health. Topics that have been covered across the agency range from contraceptive use and effectiveness, infertility and prevention of STIs, HIV and unintended pregnancy to the effects of various occupational, environmental, and physical exposures on male reproductive health function. Several publicly available, population-based surveys conducted by CDC also have examined key aspects of male health. Highlights from these CDC activities will be reviewed, and recent progress on two initiatives regarding sexual health and teen pregnancy prevention will be discussed.

Learning Areas:
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research

Learning Objectives:
Discuss current progress of CDC with male reproductive health. Explain what how the Affordable Care Act affects men's reproductive health.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am currently the Associate Director for Science for the Division of Reproductive Health at the CDC. I joined the CDC in 1996 with the Division of HIV/AIDS Prevention and previously worked with the Office of Perinatal Epidemiology at the Georgia Division of Public Health and the Department of Gynecology and Obstetrics at Emory University. I have also been a graduate instructor in epidemiology for the University of Georgia’s College of Public Health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4134.0: Affordable Care Act and the Supreme Court: Impacting male health